Abstract
Induced pluripotent stem (iPS) cells have been generated through nuclear reprogramming of somatic cells via retrovirus- or lentivirus-mediated transduction of exogenous reprogramming factors OCT3/4, SOX2, KLF4, and c-MYC. The extraembryonic amnion is considered to be a promising candidate cell source for cellular therapeutics and the generation of iPS cells because it contains a large number of cells that do not require any genetic or epigenetic modifications. In this chapter, we describe how to generate human amniotic membrane (hAM) primary cells derived from placenta and how to establish the iPS cells from these hAM cells using four reprogramming factors. The hAM-derived iPS cells could be useful for personal regenerative medicine for future infants and useful as genetic disease models and for disease-specific drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cunningham, F. G., Williams, J. W. (2005) Implantation, embryogenesis, and placenta development. Williams obstetrics. 22nd ed. New York: McGraw-Hill Professional. pp. 39–90.
Sadler, T. W. (2006) Third month to birth : the fetus and placenta. Langman’s Medical Embryology. 10th ed. Philadelphia: Lippincott Williams & Wilkins. pp. 89–109.
Portmann-Lanz, C. B., Schoeberlein, A., Huber, A., Sager, R., Malek, A., et al. (2006) Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. American journal of obstetrics and gynecology 194: 664–673.
Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., et al. (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22: 649–658.
Kawamichi, Y., Cui, C. H., Toyoda, M., Makino, H., Horie, A., et al. (2010) Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of Duchenne muscular dystrophy. J Cell Physiol 223: 695–702.
Wernig, K., Griesbacher, M., Andreae, F., Hajos, F., Wagner, J., et al. (2008) Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release 130: 192–198.
Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., et al. (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848–855.
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285–290.
Zhao, P., Ise, H., Hongo, M., Ota, M., Konishi, I., et al. (2005) Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79: 528–535.
Miki, T., Lehmann, T., Cai, H., Stolz, D. B., Strom, S. C. (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23: 1549–1559.
Tsuji, H., Miyoshi, S., Ikegami, Y., Hida, N., Asada, H., et al. (2010) Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106: 1613–1623.
Nagata, S., Toyoda, M., Yamaguchi, S., Hirano, K., Makino, H., et al. (2009) Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells 14: 1395–1404.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Humana Press
About this protocol
Cite this protocol
Toyoda, M., Nagata, S., Makino, H., Akutsu, H., Tada, T., Umezawa, A. (2011). Generation of Induced Pluripotent Stem Cells from Human Amnion Cells. In: Ye, K., Jin, S. (eds) Human Embryonic and Induced Pluripotent Stem Cells. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1007/978-1-61779-267-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-61779-267-0_18
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-266-3
Online ISBN: 978-1-61779-267-0
eBook Packages: Springer Protocols